tradingkey.logo
tradingkey.logo
Search

Mink Therapeutics Inc

INKT
Add to Watchlist
10.720USD
+0.210+2.00%
Close 05/15, 16:00ETQuotes delayed by 15 min
53.41MMarket Cap
LossP/E TTM
You can find the annual or quarterly income statement of Mink Therapeutics Inc here for insights into the performance and operational efficiency of Mink Therapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Operating expenses
13.78%2.88M
47.93%3.28M
75.48%2.99M
27.11%3.69M
-33.87%2.53M
-59.73%2.21M
-67.38%1.70M
-54.26%2.90M
-34.58%3.83M
-30.28%5.50M
-34.60%5.22M
-17.60%6.34M
-20.61%5.85M
24.99%7.89M
92.51%7.99M
72.90%7.70M
99.70%7.37M
--6.31M
--4.15M
--4.45M
--3.69M
R&D expenses
-4.58%1.20M
7.62%1.51M
-50.91%1.14M
-0.04%1.84M
-50.50%1.26M
-57.53%1.41M
-32.05%2.33M
-59.64%1.84M
-39.20%2.55M
-43.04%3.31M
-44.27%3.43M
-22.42%4.56M
-20.54%4.19M
47.14%5.81M
84.45%6.15M
10756.92%5.88M
16838.97%5.28M
--3.95M
--3.33M
--54.12K
--31.16K
Depreciation, depletion, and amortization
-28.95%36.07K
-28.41%38.56K
-30.31%43.65K
8.12%48.76K
-5.70%50.77K
0.55%53.87K
17.18%62.64K
-13.11%45.10K
17.83%53.83K
41.23%53.57K
88.02%53.45K
83.36%51.91K
68.73%45.69K
59.15%37.93K
40.15%28.43K
60.42%28.31K
67.20%27.08K
--23.83K
--20.29K
--17.65K
--16.19K
Other operating expenses
----
---22.06K
----
-100000.00%-999.00
----
--0.00
---1.79M
--1.00
----
----
----
----
----
----
----
----
----
----
----
--3.53M
--3.07M
Operating profit
----
-47.93%-3.28M
-75.48%-2.99M
-27.11%-3.69M
33.87%-2.53M
59.73%-2.21M
67.38%-1.70M
54.26%-2.90M
34.58%-3.83M
30.28%-5.50M
34.60%-5.22M
17.60%-6.34M
20.61%-5.85M
-24.99%-7.89M
-92.51%-7.99M
-72.90%-7.70M
-99.70%-7.37M
---6.31M
---4.15M
---4.45M
---3.69M
Net non-operating interest income (expenses)
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.55K
--881.32K
--805.05K
--743.70K
Special income (expenses)
100.00%0.00
298.51%571.10K
-7.17%-193.92K
-2436.01%-364.09K
---167.92K
---287.69K
---180.94K
--15.59K
----
----
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
-100.00%0.00
---49.43K
---8.87M
---1.16M
--684.44K
Other non-operating income (expenses)
173.67%58.59K
---7.87K
--240.73K
-227.27%-185.70K
---79.53K
100.00%0.00
----
--145.91K
----
99.88%-18.00
-100.00%8.00
-100.00%0.00
100.00%0.00
-102.57%-15.37K
528.34%1.56M
1795.43%1.56M
-326.52%-401.96K
--598.74K
---364.84K
--82.27K
---94.24K
Income before tax
----
-5.64%-2.60M
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Income after tax
----
-5.64%-2.60M
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Net income from continuous operations
0.88%-2.74M
-5.64%-2.60M
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Net income attributable to controlling interests
0.88%-2.74M
-5.64%-2.60M
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Net income attributable to common shareholders
0.88%-2.74M
-5.64%-2.60M
-59.84%-2.89M
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Basic earnings per share
18.09%-0.57
10.76%-0.56
-42.21%-0.65
-46.31%-1.06
36.61%-0.70
60.61%-0.62
69.19%-0.46
59.61%-0.73
34.25%-1.10
31.28%-1.58
20.93%-1.48
0.95%-1.80
27.88%-1.67
-25.76%-2.30
68.18%-1.88
75.07%-1.82
47.57%-2.32
---1.83
---5.89
---7.29
---4.43
Diluted earnings per share
18.09%-0.57
10.76%-0.56
-42.21%-0.65
-46.31%-1.06
36.61%-0.70
60.61%-0.62
69.19%-0.46
59.61%-0.73
34.25%-1.10
31.28%-1.58
20.93%-1.48
0.95%-1.80
27.88%-1.67
-25.76%-2.30
68.18%-1.88
75.07%-1.82
47.57%-2.32
---1.83
---5.89
---7.29
---4.43
Dividend per share
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI